A Presentation that promotes Evidence-Based Psychiatry and informed clinical decision making in the daily practice of Psychiatry. Prepared by Dr Yasser Amer and Dr Maged Elesely
5. Learning Objectives
1. Concepts and Definitions: EBM, CPGs
2. Why do we need CPGs ?
3. Who needs CPGs ?
4. How to find CPGs on the Web?
5. How do we react to CPGs?
CPGs Development, Adaptation, Dissemination
and Implementation
7. Two Different Approaches to
Evidence-Based Psychiatry Practice
Clinical Practice Guidelines (CPGs)
•“Top-down” approach
• Tell clinicians how to practice
• Favored by health care systems
Evidence-Based Medicine (EBM)
•“Bottom-up” approach
• Teach clinicians how to find answers
• Favored by medical educators
8. EBP definition
The integration of best research evidence
with clinical expertise and patient
values
Sackett et al 2000
EVIDENCE – BASED
PSYCHIATRY
10. EBM Resources
• Cochrane library
http://www.cochrane.org/
A lot of ready appraised studies that answer
PICO questions (High quality SRs and
RCTs).
• Clinical Evidence - BMJ:
http://clinicalevidence.bmj.com/x/index.html
11. Clinical Practice Guidelines (CPGs)
Definition: (old)
“Systematically developed statements to assist
practitioner and patient decisions about
appropriate health care for specific clinical
circumstances” (Institute of Medicine 1990).
Increasing international interest in the
development and implementation of CPGs.
12. CPGs New Definition
CPGs are “Statements that include
Recommendations intended to optimize
patient care that are informed by a
Systematic Review of evidence and an
assessment of the benefits and harms of
alternative care options”.
Committee on Standards for Developing
Trustworthy CPGs (IOM-AHRQ) 2011
13.
14. Rationale for CPGs
• Worldwide concerns about:▫ Unexplained variations in clinical practice
▫ Rising health care costs
▫ Exponential growth of information ????
• Aim of CPGs:▫ To facilitate more consistent, effective and
efficient practice and improve health
outcomes for patients
20. • Specialized Psychiatry societies:• American Psychiatry Association
• American Academy of Child & Adolescent Psychiatry
• Canadian Network for Mood & Anxiety Treatments
• The Maudsley Hospital, NHS, UK
• National CPGs agencies:
NICE - UK
SIGN - UK
34. Guidelines International Network (G-I-N)
www.g-i-n.net
EBHC-KT Chair, King Saud University
Org. Member since 2009 (3rd Member from MENA Countries)
35.
36. Shaikh Bahamdan’s Research Chair for
Evidence-Based Health Care & Knowledge
Translation
Member of G-I-N since Oct. 2009
Free access to International CPG Library of G-I-N
45. Extensive search for BAD CPGs
•
•
•
•
•
International (13) 2004-2011
USA (8) 2004-2011
UK (4) 2005-2013
Canadian (12) 2004-2013
Review articles (evidence) (28) 2007-2013
52. Guideline Adaptation
• Is the systematic approach to the endorsement and/or
modification of a guideline(s) produced in one cultural
and organizational setting for application in a different
context. Adaptation may be used as an alternative to
de novo guideline development, e.g., for customizing
(an) existing guideline(s) to suit the local context.
• http://www.adapte.org/
59. Implementing Guidelines
If CPGs are to have a
positive impact on patient
care outcomes they must
be implemented into daily
clinical practice
60. CPGs Are Not Rules
• Expect the vast majority of practice to fall within
CPGs (80 % - 90 % Rule)
• Deviation from CPGs is allowed for specific patients
with specific circumstances.
• When such deviation occurs an individual clinician
is expected to explain the rationale.
• Strong evidence (Level 1 & 2) are expected to be
followed.
• Weaker evidence (Level 3 & 4) can be handled
differently .
61. Clinical Scenario
An 82 year-old female with dementia is admitted to the
Black Lion Hospital for recurrent falls. She is found to have
Alzheimer’s dementia and she is on no medications. The patient
has never learned to read or write so a Mini Mental Status
Examination was not possible. The diagnosis was made on clinical
grounds with collateral from her family. However, she is agitated at
night. Her family is against antipsychotic medication and the team
has asked if there are any other classes of medication that are
helpful for agitation. She will return to her family in the
countryside once this problem is addressed and the family cannot
manage her otherwise. The treating team questions the role of
antidepressants in treating behavioural symptoms in dementia
patients and would like to know if there is support for a specific
antidepressant in this case?
64. Acknowledgments
• Prof. Dr. Lubna Al-Ansary
Professor, Consultant, Family Medicine
Holder, Shaikh Bahamdan EBHC-KT Chair
Head, CPGs Committee, University Hospitals
King Saud University
Member, G-I-N Board of Trustees
Co-chair, G-I-N Adaptation Working Group
• Prof. Dr. Eman Abahussein
Professor, Consultant, Psychiatry
Head, Psychiatry CPGs Subcommittee
College of Medicine & King Khalid University Hospital
King Saud University
• Dr. Yasser S. Amer
Pediatrician - Healthcare Informatician
CPGs General Coordinator, QMD, CPGs Committee,
King Saud University Hospitals (KKUH/KAUH)
Member, G-I-N Adaptation Working Group/Steering Committee